Lan Danmei, Wang Wenzhao, Zhuang Jianhua, Zhao Zhongxin
Department of Neurology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Mol Med Rep. 2015 Mar;11(3):1655-60. doi: 10.3892/mmr.2014.3011. Epub 2014 Nov 27.
The aim of the present study was to examine the effects of proteasome inhibitor (PI)‑induced autophagy on PC12 cells overexpressing A53T mutant α‑synuclein (α‑syn) by detecting alterations in the levels of microtubule‑associated protein 1A/1B light chain (LC3)+ autophagosomes and the lysotracker‑positive autolysosomes using immunofluorescence, the expression of LC3‑II using western blot analysis and the morphology of PC12 cells using transmission electron microscopy. It was found that the addition of MG132 (500 nmol/l) significantly increased the number of autophagosomes and autolysosomes and upregulated the expression of LC3‑II. The autophagy inhibitor 3‑methyladenine (3‑MA) completely inhibited the autophagy induced by MG132 (500 nmol/l). The autophagy enhancer trehalose significantly increased the number of autophagosomes and autolysosomes and improved the protein level of LC3‑II induced by MG132. To examine the effect of PI‑induced autophagy on the degradation of A53T mutant α‑syn, the expression of α‑syn was detected by western blot analysis. It was revealed that MG132 increased the expression of A53T α‑syn and trehalose counteracted the increase of A53T α‑syn induced by MG132. Combined inhibition of 3‑MA and PI significantly increased the accumulation of A53T α‑syn as compared with treatment using either single agent. In addition, combination of MG132 (500 nmol/l) with trehalose (50 mmol/l) or 3‑MA (2 mmol/l) markedly decreased the cell viability as compared with treatment using either single agent individually as demonstrated using a 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide assay. These results suggest that the PI, MG132, could induce autophagy in PC12 cells overexpressing A53T mutant α‑syn and this autophagy could be completely inhibited by 3‑MA, indicating that PI‑induced autophagy is mediated by the upregulation of the macroautophagy class III PI3K pathway. PI‑induced autophagy may act as a compensatory degradation system for degradation of A53T α‑syn when the ubiquitin‑proteasome system is impaired. Autophagy activation may directly contribute to the survival of PC12 cells treated with proteasome inhibitors. The present study may assist in illuminating the association between PI and autophagy in the pathogenesis of Parkinson's disease.
本研究的目的是通过免疫荧光检测微管相关蛋白1A/1B轻链(LC3)+自噬体和溶酶体示踪剂阳性自噬溶酶体水平的变化、蛋白质印迹分析检测LC3-II的表达以及透射电子显微镜观察PC12细胞的形态,来研究蛋白酶体抑制剂(PI)诱导的自噬对过表达A53T突变体α-突触核蛋白(α-syn)的PC12细胞的影响。结果发现,添加MG132(500 nmol/l)可显著增加自噬体和自噬溶酶体的数量,并上调LC3-II的表达。自噬抑制剂3-甲基腺嘌呤(3-MA)可完全抑制MG132(500 nmol/l)诱导的自噬。自噬增强剂海藻糖可显著增加自噬体和自噬溶酶体的数量,并提高MG132诱导的LC3-II的蛋白水平。为了研究PI诱导的自噬对A53T突变体α-syn降解的影响,通过蛋白质印迹分析检测α-syn的表达。结果显示,MG132增加了A53T α-syn的表达,而海藻糖可抵消MG132诱导的A53T α-syn的增加。与单一药物处理相比,3-MA和PI联合抑制显著增加了A53T α-syn的积累。此外,与单独使用单一药物处理相比,MG132(500 nmol/l)与海藻糖(50 mmol/l)或3-MA(2 mmol/l)联合使用显著降低了细胞活力,这通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐检测得以证实。这些结果表明,PI,即MG132,可在过表达A53T突变体α-syn的PC12细胞中诱导自噬,且这种自噬可被3-MA完全抑制,这表明PI诱导的自噬是由III类PI3K途径的上调介导的。当泛素-蛋白酶体系统受损时,PI诱导的自噬可能作为A53T α-syn降解的补偿性降解系统。自噬激活可能直接有助于蛋白酶体抑制剂处理的PC12细胞的存活。本研究可能有助于阐明PI与自噬在帕金森病发病机制中的关联。